Exploration of the key active ingredients and mechanisms of Sparganii Rhizoma-Curcumae Rhizoma compatible formulation against human colorectal cancer through network pharmacology and in vitro experiments

Introduction: Sparganii Rhizoma-Curcumae Rhizoma (SR-CR) formulation may offer an effective treatment for human colorectal cancer (CRC). However, the active ingredients and underlying mechanisms of this herbal formulation remain unclear. Methods: This study integrates network pharmacology, molecular...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Hongyan Lin, Dongxuan Ai, Xinling Wang, Shuaijun Cui, Xinghong Li, Bangmei Ye, Lingyu Ruan, Jing Xu, Liqun Wang
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2024-12-01
Ráidu:	Pharmacological Research - Modern Chinese Medicine
Fáttát:	Sparganii Rhizoma-Curcumae Rhizoma (SR-CR) Network pharmacology Colorectal cancer (CRC) Molecular docking
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S266714252400174X
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!